JEET JOSHI: Open Payments
NPI 1356634901 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 29 payments from 10 companies in 2025. Trend: 2023 $878 · 2024 $774 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $169 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Supernus Pharmaceuticals, Inc. | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: LYBALVI, CAPLYTA, REXULTI, Qelbree, HETLIOZ, Auvelity, INVEGA SUSTENNA, INGREZZA.
Industry payments across DE — which companies pay providers there.
